DC-81-Indole conjugate agent induces mitochondria mediated apoptosis in human melanoma A375 cells

Area of Science:

• Pharmacology
• Molecular Biology
• Oncology

Background:

• Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) are potent antitumor agents.
• Previous work established efficient synthesis of PBD-indole carboxylate hybrids.
• The anticancer mechanism of these hybrids, specifically IN6CPBD, remained largely unelucidated.

Purpose of the Study:

• To investigate the anticancer mechanism of the PBD hybrid IN6CPBD in human melanoma A375 cells.
• To determine if IN6CPBD induces apoptosis and assess its effects on mitochondrial function.

Main Methods:

• Cytotoxicity assays comparing IN6CPBD and DC-81.
• Flow cytometry to analyze cell cycle (sub-G1 population) and apoptosis (annexin V binding).
• Western blotting for caspase-3 and poly (ADP-ribose) polymerase (PARP) cleavage.
• Mitochondrial function assessment: membrane potential (ΔΨm), intracellular pH (pHi), ATP synthesis, reactive oxygen species (ROS) generation, and cytochrome c release.

Main Results:

• IN6CPBD exhibited higher cytotoxicity than the parent compound DC-81.
• IN6CPBD induced significant apoptosis, evidenced by increased sub-G1 population, annexin V binding, caspase-3 degradation, and PARP cleavage.
• Treatment with IN6CPBD led to mitochondrial dysfunction, including loss of membrane potential, decreased pHi, reduced ATP synthesis, increased ROS, and cytochrome c release.

Conclusions:

• IN6CPBD effectively induces apoptosis in human melanoma A375 cells.
• The mechanism involves significant mitochondrial dysfunction, culminating in caspase-dependent PARP cleavage and subsequent cell death.
• IN6CPBD represents a promising agent for melanoma treatment, warranting further investigation.